Skip to main content

Table 1 Sociodemographic and clinical characteristics of patients and controls

From: Natural IgG antibodies to β amyloid are decreased in patients with Parkinson’s disease

 

Healthy Controls

PD

AD

VAD

For trend

p-value

15

15

30

31

 

Age (yy)

69.13 ± 3.55

74.25 ± 2.57

72.83 ± 1.34

75.30 ± 1.74

0.25

Male Sex (n° %)

5 (33.3)

9 (56.3)

12 (40.0)

8 (26.7)

0.31

MMSE score

26.92 ± 1.77

25.75 ± 0.65

20.19 ± 1.45

19.56 ± 0.99*

0.01

Education (yy)

3.73 ± 0.97

4.25 ± 0.30

3.53 ± 0.48

3.50 ± 0.70

0.88

CIRS score

7.07 ± 1.83

1.94 ± 0.88 *

5.67 ± 0.76

7.59 ± 0.86

0.003

Disease diagnosed (mo)

N.A

16 ± 4

30 ± 14

18 ± 11

0.77

  1. PD Parkinson’s Disease, AD Alzheimer Dementia, VAD Vascular Dementia, CIRS Cumulative Illness Rating Scale
  2. *denotes p < 0.05 vs control; N.A not applicable